Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 174
Filtrer
1.
Front Aging ; 5: 1393216, 2024.
Article de Anglais | MEDLINE | ID: mdl-38757144

RÉSUMÉ

Various so-called dietary restriction paradigms have shown promise for extending health and life. All such paradigms rely on ad libitum (hereafter ad lib) feeding, something virtually never employed in animals whose long-term health we value, either as a control or, except for food restriction itself, for both control and treatment arms of the experiment. Even though the mechanism(s) remain only vaguely understood, compared to ad lib-fed animals a host of dietary manipulations, including calorie restriction, low protein, methionine, branched-chain amino acids, and even low isoleucine have demonstrable health benefits in laboratory species in a standard laboratory environment. The remaining challenge is to determine whether these health benefits remain in more realistic environments and how they interact with other health enhancing treatments such as exercise or emerging geroprotective drugs. Here we review the current state of the field of amino acid restriction on longevity of animal models and evaluate its translational potential.

2.
J Prev Alzheimers Dis ; 6(4): 242-247, 2019.
Article de Anglais | MEDLINE | ID: mdl-31686096

RÉSUMÉ

Screen failure rates in Alzheimer's disease (AD) clinical trial research are unsustainable, with participant recruitment being a top barrier to AD research progress. The purpose of this project was to understand the neuropsychological, psychiatric, and functional features of individuals who failed screening measures for AD trials. Previously collected clinical data from 38 patients (aged 50-83) screened for a specific industry-sponsored clinical trial of MCI/early AD (Biogen 221AD302, [EMERGE]) were analyzed to identify predictors of AD trial screen pass/fail status. Worse performance on non-memory cognitive domains like crystalized knowledge, executive functioning, and attention, and higher self-reported anxiety, was associated with failing the screening visit for the EMERGE AD clinical trial, whereas we were not able to detect a relationship between screening status and memory performance, self-reported depression, or self-reported daily functioning. By identifying predictors of AD trial screen passing/failure, this research may influence decision-making about which patients are most likely to successfully enroll in a trial, thereby potentially lowering participant burden, maximizing study resources, and reducing costs.


Sujet(s)
Maladie d'Alzheimer/traitement médicamenteux , Essais cliniques de phase III comme sujet , Dysfonctionnement cognitif/traitement médicamenteux , Détermination de l'admissibilité , Sélection de patients , Activités de la vie quotidienne , Sujet âgé , Sujet âgé de 80 ans ou plus , Maladie d'Alzheimer/physiopathologie , Maladie d'Alzheimer/psychologie , Anticorps monoclonaux humanisés/usage thérapeutique , Anxiété/psychologie , Attention , Essais cliniques comme sujet , Dysfonctionnement cognitif/physiopathologie , Dysfonctionnement cognitif/psychologie , Comorbidité , Études transversales , Dépression/psychologie , Fonction exécutive , Femelle , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Indice de gravité de la maladie
3.
J Small Anim Pract ; 59(11): 681-690, 2018 Nov.
Article de Anglais | MEDLINE | ID: mdl-30039567

RÉSUMÉ

OBJECTIVE: To describe a large population of dogs with a diagnosis of hyperadrenocorticism at the time of death in North American veterinary teaching hospitals, and to identify comorbid conditions associated with hyperadrenocorticism. MATERIALS AND METHODS: Retrospective cohort study of 1519 dogs with hyperadrenocorticism from a population of 70,574 dogs reported to the Veterinary Medical Database. Signalment, presence or absence of hyperadrenocorticism, aetiology of hyperadrenocorticism (if described), frequency of select comorbidities and causes of death were evaluated in dogs with and without hyperadrenocorticism. RESULTS: Hyperadrenocorticism was more frequent in females. Neutering was associated with a minor, but significant, increase in the odds of hyperadrenocorticism. Hyperadrenocorticism was the presumed cause of death of 393 (25∙9%) of affected dogs. When aetiology was specified (527 dogs, corresponding to 34∙7% of the cases), pituitary-dependent hyperadrenocorticism [387 (73∙4%) out of 527 dogs] was more common than functional adrenocortical tumour [136 (25∙8%) out of 527 dogs). Hyperadrenocorticism was over-represented in certain expected (miniature poodle, dachshund) and unexpected (Irish setter, bassett hound) breeds compared with the population at large. Of the select comorbidities investigated, dogs with hyperadrenocorticism were at increased risk for concurrent diabetes mellitus, urinary tract infection, urolithiasis, hypertension, gall bladder mucocoele and thromboembolic disease compared with dogs without hyperadrenocorticism. CLINICAL SIGNIFICANCE: Hyperadrenocorticism is significantly associated with certain comorbid conditions but is not a major cause of mortality in affected dogs. Documented patterns now provide targets for prospective clinical research.


Sujet(s)
Hypercorticisme/médecine vétérinaire , Maladies des chiens/mortalité , Hypercorticisme/épidémiologie , Hypercorticisme/mortalité , Animaux , Cause de décès , Études de cohortes , Comorbidité , Bases de données factuelles , Maladies des chiens/épidémiologie , Chiens , Femelle , Hôpitaux vétérinaires , Hôpitaux d'enseignement , Mâle , Études rétrospectives , Spécificité d'espèce , États-Unis/épidémiologie
4.
J Prev Alzheimers Dis ; 4(2): 87-92, 2017.
Article de Anglais | MEDLINE | ID: mdl-28966919

RÉSUMÉ

BACKGROUND: Practice effects, which are improvements in cognitive test scores due to repeated exposure to testing materials, may provide information about Alzheimer's disease pathology, which could be useful for clinical trials enrichment. OBJECTIVES: The current study sought to add to the limited literature on short-term practice effects on cognitive tests and their relationship to amyloid deposition on neuroimaging. PARTICIPANTS: Twenty-seven, non-demented older adults (9 cognitively intact, 18 with mild cognitive impairment) received amyloid imaging with 18F-Flutemetamol, and two cognitive testing sessions across one week to determine practice effects. RESULTS: A composite measure of 18F-Flutemetamol uptake correlated significantly with all seven cognitive tests scores on the baseline battery (r's = -0.61 - 0.59, all p's<0.05), with higher uptake indicating poorer cognition. Practice effects significantly added to the relationship (above and beyond the baseline associations) with 18F-Flutemetamol uptake on 4 of the 7 cognitive test scores (partial r's = -0.45 - 0.44, p's<0.05), with higher uptake indicating poorer practice effects. The odds ratio of being "amyloid positive" was 13.5 times higher in individuals with low practice effects compared to high practice effects. CONCLUSIONS: Short-term practice effects over one week may be predictive of progressive dementia and serve as an affordable screening tool to enrich samples for preventative clinical trials in Alzheimer's disease.

5.
CPT Pharmacometrics Syst Pharmacol ; 6(3): 153-155, 2017 03.
Article de Anglais | MEDLINE | ID: mdl-28109071

RÉSUMÉ

The explosive growth of patient-specific genomic information relevant to drug therapy will continue to be a defining characteristic of biomedical research. To implement drug-based personalized medicine (PM) for patients, clinicians need actionable information incorporated into electronic health records (EHRs). New clinical decision support (CDS) methods and informatics infrastructure are required in order to comprehensively integrate, interpret, deliver, and apply the full range of genomic data for each patient.


Sujet(s)
Systèmes d'aide à la décision clinique , Dossiers médicaux électroniques , Génomique/méthodes , Médecine de précision/méthodes , Bases de données génétiques/tendances , Systèmes d'aide à la décision clinique/tendances , Dossiers médicaux électroniques/tendances , Génomique/tendances , Humains , Médecine de précision/tendances
6.
Clin Pharmacol Ther ; 95(5): 499-500, 2014 May.
Article de Anglais | MEDLINE | ID: mdl-24561393

RÉSUMÉ

The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing were originally published in April 2012. We reviewed recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the Supplementary Material online and included additional resources for applying CPIC guidelines to the electronic health record. Up-to-date information can be found at PharmGKB (http://www.pharmgkb.org).


Sujet(s)
Agents antiVIH/administration et posologie , Didéoxynucléosides/administration et posologie , Antigènes HLA-B/génétique , Dossiers médicaux électroniques , Génotype , Humains , Pharmacogénétique
7.
J Endocrinol Invest ; 36(2): 111-7, 2013 Feb.
Article de Anglais | MEDLINE | ID: mdl-22522495

RÉSUMÉ

BACKGROUND: Aging is associated with a decline in skeletal muscle size.Muscle is critical both for mobility and glucose disposal. While resistance exercise (RE) increases muscle mass and function in the elderly, its role in improving glucose utilization is less clear. AIMS: To investigate whether muscle size was linked with insulin sensitivity (IS) in elders with diabetes following RE and if regional muscle glucose uptake differed from systemic glucose utilization. METHODS: Seven (68.4 ± 5.9 yr) adults with diabetes participated. After 16 weeks of RE, within 24 h (post 1) and after 1 week of no exercise (post 2), lean tissue cross-sectional area (CSA) and IS via glucose infusion rate (GIR) were assessed along with a standardized 18-F fluorodeoxyglucose (FDG)-positron emission tomography uptake value (SUV). RESULTS: CSA increased between pre-test (108.5 ± 35.3 cm2) and post 1 (116.8 ± 40.9 cm2), p=0.02 and did not differ at post 2 (116.0 ± 39.3 cm2). GIR during the 40 mU/m2/min insulin clamp differed between pretest (22.0 ± 15.8 mg/kg/min) and post 1 (67.9 ± 72.8 mg/kg/min), and post 1 and post 2 (25.0 ± 27.2 mg/kg/min) but not between pre-test and post 2. GIR results during the 200 mU/m2/min insulin clamps also differed between pre-test and post 1, and post 1 and post 2 but not between pre-test and post 2. FDG-SUV increased between pre-test (1.1 ± 0.2) and post 1 (1.4 ± 0.3), and remained stable between post 1 and post 2 (1.4 ± 0.4). CONCLUSION: RE that increased muscle size and FDG-SUV improved IS 24 h but not 1 week after exercise training.


Sujet(s)
Vieillissement/métabolisme , Diabète de type 2/métabolisme , Glucose/métabolisme , Insulinorésistance/physiologie , Muscles squelettiques/métabolisme , Entraînement en résistance/tendances , Sujet âgé , Vieillissement/physiologie , Diabète de type 2/physiopathologie , Diabète de type 2/thérapie , Femelle , Glucose/physiologie , Humains , Mâle , Adulte d'âge moyen , Muscles squelettiques/physiologie , Entraînement en résistance/méthodes , Facteurs temps
9.
J Hosp Infect ; 79(4): 317-22, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-21945067

RÉSUMÉ

There is little published evidence regarding whether heparin lock solutions containing preservatives prevent catheter-related infections. However, adverse effects from preservative-containing flushes have been documented in neonates, leading many hospitals to avoid their use altogether. Infection control records from 1982 to 2008 at St. Jude Children's Research Hospital (SJCRH) were reviewed regarding the incidence of catheter-related infections and the use of preservative-containing intravenous locks. In addition, the antimicrobial activities of heparin lock solution containing the preservatives parabens (0.165%) or benzyl alcohol (0.9%), and 70% ethanol were examined against Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, Bacillus cereus, Pseudomonas aeruginosa and Candida albicans, and compared with preservative-free saline with and without heparin. Growth was assessed after exposure to test solutions for 0, 2, 4 and 24h at 35 °C. The activities of preservatives were assessed against both planktonic (free-floating) and sessile (biofilm-embedded) micro-organisms using the MBEC Assay. Infection control records revealed two periods of increased catheter-related infections, corresponding with two intervals when preservative-free heparin was used at SJCRH. Heparin solution containing preservatives demonstrated significant antimicrobial activity against both planktonic and sessile forms of all six microbial species. Ethanol demonstrated the greatest antimicrobial activity, especially following short incubation periods. Heparin lock solutions containing the preservatives parabens or benzyl alcohol, and 70% ethanol demonstrated significant antimicrobial activity against both planktonic and sessile micro-organisms commonly responsible for catheter-related infections. These findings, together with the authors' historical infection control experience, support the use of preservatives in intravenous lock solutions to reduce catheter related infections in patients beyond the neonatal period.


Sujet(s)
Infections sur cathéters/épidémiologie , Infections sur cathéters/prévention et contrôle , Cathétérisme/effets indésirables , Cathéters/microbiologie , Désinfection/méthodes , Conservateurs pharmaceutiques/pharmacologie , Bactéries/effets des médicaments et des substances chimiques , Alcool benzylique/pharmacologie , Éthanol/pharmacologie , Humains , Incidence , Tests de sensibilité microbienne , Parabènes/pharmacologie
10.
Neurogastroenterol Motil ; 23(7): 673-e279, 2011 Jul.
Article de Anglais | MEDLINE | ID: mdl-21426440

RÉSUMÉ

BACKGROUND: Colitis is associated with increased excitability of afterhyperpolarization neurons (AH neurons) and facilitated synaptic transmission in the myenteric plexus. These changes are accompanied by disrupted propulsive motility, particularly in ulcerated regions. This study examined the relationship between myenteric AH neuronal hyperexcitability and disrupted propulsive motility. METHODS: The voltage-activated Na(+) channel opener veratridine, the intermediate conductance Ca(2+) -activated K(+) channel inhibitor TRAM-34 and the 5-HT(4) receptor agonist tegaserod were used to evaluate the effects of neuronal hyperexcitability and synaptic facilitation on propulsive motility in normal guinea pig distal colon. Because trinitrobenzene sulfonic acid (TNBS)-colitis-induced hyperexcitability of myenteric afferent neurons involves increases in hyperpolarization-activated, cyclic nucleotide-gated (HCN) channel activity, the HCN channel inhibitors Cs(+) and ZD7288 were used to suppress AH neuronal activity in TNBS-colitis. KEY RESULTS: In non-inflamed preparations, veratridine halted propulsive motility (P<0.001). The rate of propulsive motor activity was significantly reduced following addition of TRAM-34 and tegaserod (P<0.001). In TNBS-inflamed preparations, in which motility was temporarily halted or obstructed at sites of ulceration, both Cs(+) and ZD7288 normalized motility through the inflamed regions. Immunohistochemistry studies demonstrated that the proportion of AH neurons in the myenteric plexus was unchanged in ulcerated regions, but there was a 10% reduction in total number of neurons per ganglion. CONCLUSIONS AND INFERENCES: These findings support the concept that inflammation-induced neuroplasticity in myenteric neurons, involving changes in ion channel activity that lead to enhanced AH neuronal excitability, can contribute to impaired propulsive colonic motility.


Sujet(s)
Colite/physiopathologie , Côlon/physiopathologie , Système nerveux entérique/physiologie , Motilité gastrointestinale/physiologie , Activité motrice/physiologie , Plexus myentérique/physiologie , Animaux , Colite/induit chimiquement , Côlon/effets des médicaments et des substances chimiques , Système nerveux entérique/effets des médicaments et des substances chimiques , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Cochons d'Inde , Indoles/pharmacologie , Modèles animaux , Activité motrice/effets des médicaments et des substances chimiques , Plexus myentérique/effets des médicaments et des substances chimiques , Pyrazoles/pharmacologie , Pyrimidines/pharmacologie , Acide 2,4,6-trinitro-benzènesulfonique/effets indésirables , Vératridine/pharmacologie
11.
Intensive Care Med ; 34(12): 2273-8, 2008 Dec.
Article de Anglais | MEDLINE | ID: mdl-18682917

RÉSUMÉ

OBJECTIVE: To compare the pattern of lung uptake of 18F-fluorodeoxyglucose (FDG) by positron emission tomography (PET) imaging in patients with lung contusion that developed or did not progress to acute respiratory distress syndrome (ARDS). DESIGN: Prospective, observational study. SETTING: Trauma Center (academic urban hospital). PATIENTS AND INTERVENTIONS: Eight patients with blunt thoracic trauma and pulmonary contusion, confirmed by computed tomography (CT) on admission, underwent repeat CT and FDG-PET (on the same day) 24-72 h after admission. RESULTS: No subjects met the criteria for ARDS at the time of the PET and second CT. Four subjects subsequently developed ARDS 1-3 days after the PET scan; the other four did not develop the syndrome. Three of the four subjects who subsequently developed ARDS showed diffuse FDG uptake throughout the entire lungs, while those who did not develop ARDS showed significant FDG uptake only in areas of focal lung opacity (non or poorly aerated lung units) on CT. FDG uptake in normally aerated lung regions was higher for those who subsequently developed ARDS than those who did not, approaching statistical significance. The normally aerated tissue:liver ratio was significantly higher in subjects who developed ARDS than in those who did not (P = 0.029). CONCLUSION: In this small series of patients with thoracic trauma, diffuse lung uptake of FDG was detected by PET imaging 1-3 days prior to clinically determined ARDS.


Sujet(s)
Tomographie par émission de positons , /diagnostic , Lésion pulmonaire aigüe/complications , Adolescent , Adulte , Sujet âgé , Études de cohortes , Diagnostic précoce , Femelle , Fluorodésoxyglucose F18 , Humains , Mâle , Adulte d'âge moyen , Projets pilotes , Valeur prédictive des tests , Radiopharmaceutiques , /étiologie , Centres de traumatologie , Jeune adulte
12.
J Neurol Neurosurg Psychiatry ; 79(11): 1275-81, 2008 Nov.
Article de Anglais | MEDLINE | ID: mdl-18469027

RÉSUMÉ

BACKGROUND: Mild traumatic brain injury (MTBI) is a significant public health problem affecting approximately 1 million people annually in the USA. A total of 10-15% of individuals are estimated to have persistent post-traumatic symptoms. This study aimed to determine whether focused, scheduled telephone counselling during the first 3 months after MTBI decreases symptoms and improves functioning at 6 months. METHODS: This was a two-group, parallel, randomised clinical trial with the outcome assessed by blinded examiner at 6 months after injury. 366 of 389 eligible subjects aged 16 years or older with MTBI were enrolled in the emergency department, with an 85% follow-up completion rate. Five telephone calls were completed, individualised for patient concerns and scripted to address education, reassurance and reactivation. Two composites were analysed, one relating to post-traumatic symptoms that developed or worsened after injury and their impact on functioning, the other related to general health status. RESULTS: The telephone counselling group had a significantly better outcome for symptoms (6.6 difference in adjusted mean symptom score, 95% confidence interval (CI) 1.2 to 12.0), but no difference in general health outcome (1.5 difference in adjusted mean functional score, 95% CI 2.2 to 5.2). A smaller proportion of the treatment group had each individual symptom (except anxiety) at assessment. Similarly, fewer of the treatment group had daily functioning negatively impacted by symptoms with the largest differences in work, leisure activities, memory and concentration and financial independence. CONCLUSIONS: Telephone counselling, focusing on symptom management, was successful in reducing chronic symptoms after MTBI. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov, #NCT00483444.


Sujet(s)
Lésions encéphaliques/psychologie , Assistance , Assistance par téléphone , Troubles de stress post-traumatique , Adulte , Lésions encéphaliques/imagerie diagnostique , Démographie , Femelle , Échelle de coma de Glasgow , Humains , Mâle , Indice de gravité de la maladie , Troubles de stress post-traumatique/étiologie , Troubles de stress post-traumatique/prévention et contrôle , Troubles de stress post-traumatique/psychologie , Tomodensitométrie
13.
Am J Physiol Regul Integr Comp Physiol ; 294(3): R884-94, 2008 Mar.
Article de Anglais | MEDLINE | ID: mdl-18094064

RÉSUMÉ

Activation of 5-HT1A receptors in the medullary raphé decreases sympathetically mediated brown adipose tissue (BAT) thermogenesis and peripheral vasoconstriction when previously activated with leptin, LPS, prostaglandins, or cooling. It is not known whether shivering is also modulated by medullary raphé 5-HT1A receptors. We previously showed in conscious piglets that activation of 5-HT1A receptors with (+/-)-8-hydroxy-2-(dipropylamino)-tetralin (8-OH-DPAT) in the paragigantocellularis lateralis (PGCL), a medullary region lateral to the raphé that contains substantial numbers of 5-HT neurons, eliminates rapid eye movement (REM) sleep and decreases shivering in a cold environment, but does not attenuate peripheral vasoconstriction. Hoffman JM, Brown JW, Sirlin EA, Benoit AM, Gill WH, Harris MB, Darnall RA. Am J Physiol Regul Integr Comp Physiol 293: R518-R527, 2007. We hypothesized that, during cooling, activation of 5-HT1A receptors in the medullary raphé would also eliminate REM sleep and, in contrast to activation of 5-HT1A receptors in the PGCL, would attenuate both shivering and peripheral vasoconstriction. In a continuously cool environment, dialysis of 8-OH-DPAT into the medullary raphé resulted in alternating brief periods of non-REM sleep and wakefulness and eliminated REM sleep, as observed when 8-OH-DPAT is dialyzed into the PGCL. Moreover, both shivering and peripheral vasoconstriction were significantly attenuated after 8-OH-DPAT dialysis into the medullary raphé. The effects of 8-OH-DPAT were prevented after dialysis of the selective 5-HT1A receptor antagonist WAY-100635. We conclude that, during cooling, exogenous activation of 5-HT1A receptors in the medullary raphé decreases both shivering and peripheral vasoconstriction. Our data are consistent with the hypothesis that neurons expressing 5-HT1A receptors in the medullary raphé facilitate spinal motor circuits involved in shivering, as well as sympathetic stimulation of other thermoregulatory effector mechanisms.


Sujet(s)
Noyaux du raphé/physiologie , Agonistes des récepteurs 5-HT1 de la sérotonine , Agonistes des récepteurs de la sérotonine/pharmacologie , Frissonnement/effets des médicaments et des substances chimiques , Sommeil/effets des médicaments et des substances chimiques , 7-Dipropylamino-5,6,7,8-tétrahydro-1-naphtol/pharmacologie , Animaux , Température du corps/effets des médicaments et des substances chimiques , Basse température , Conscience/physiologie , Dialyse , Femelle , Rythme cardiaque/effets des médicaments et des substances chimiques , Mâle , Moelle allongée/physiologie , Pléthysmographie , Noyaux du raphé/effets des médicaments et des substances chimiques , Mécanique respiratoire/effets des médicaments et des substances chimiques , Sommeil paradoxal/effets des médicaments et des substances chimiques , Suidae , Vasoconstriction/effets des médicaments et des substances chimiques
14.
Clin Trials ; 4(5): 499-513, 2007.
Article de Anglais | MEDLINE | ID: mdl-17942466

RÉSUMÉ

BACKGROUND: An intermediate endpoint is hypothesized to be in the middle of the causal sequence relating an independent variable to a dependent variable. The intermediate variable is also called a surrogate or mediating variable and the corresponding effect is called the mediated, surrogate endpoint, or intermediate endpoint effect. Clinical studies are often designed to change an intermediate or surrogate endpoint and through this intermediate change influence the ultimate endpoint. In many intermediate endpoint clinical studies the dependent variable is binary, and logistic or probit regression is used. PURPOSE: The purpose of this study is to describe a limitation of a widely used approach to assessing intermediate endpoint effects and to propose an alternative method, based on products of coefficients, that yields more accurate results. METHODS: The intermediate endpoint model for a binary outcome is described for a true binary outcome and for a dichotomization of a latent continuous outcome. Plots of true values and a simulation study are used to evaluate the different methods. RESULTS: Distorted estimates of the intermediate endpoint effect and incorrect conclusions can result from the application of widely used methods to assess the intermediate endpoint effect. The same problem occurs for the proportion of an effect explained by an intermediate endpoint, which has been suggested as a useful measure for identifying intermediate endpoints. A solution to this problem is given based on the relationship between latent variable modeling and logistic or probit regression. LIMITATIONS: More complicated intermediate variable models are not addressed in the study, although the methods described in the article can be extended to these more complicated models. CONCLUSIONS: Researchers are encouraged to use an intermediate endpoint method based on the product of regression coefficients. A common method based on difference in coefficient methods can lead to distorted conclusions regarding the intermediate effect.


Sujet(s)
Marqueurs biologiques , Modèles logistiques , Essais cliniques comme sujet/statistiques et données numériques , Humains , États-Unis
15.
Am J Physiol Regul Integr Comp Physiol ; 293(1): R518-27, 2007 Jul.
Article de Anglais | MEDLINE | ID: mdl-17409258

RÉSUMÉ

Activation of 5-HT(1A) receptors in the medullary raphé decreases sympathetic outflow to thermoregulatory mechanisms, including brown adipose tissue (BAT), thermogenesis, and peripheral vasoconstriction when these mechanisms are previously activated with leptin, prostaglandins, or cooling. These same mechanisms are also inhibited during rapid eye movement (REM) sleep. It is not known whether shivering is also modulated by medullary raphé neurons. We previously showed in the conscious piglet that activation of 5-HT(1A) receptors with 8-OH-DPAT (DPAT) in the paragigantocellularis lateralis (PGCL), a medullary region lateral to the midline raphé that contains 5-HT neurons, decreases heart rate, body temperature and muscle activity during non-rapid eye movement (NREM) sleep. We therefore hypothesized that activation of 5-HT(1A) receptors in the PGCL would also attenuate shivering and peripheral vasoconstriction during cooling. During REM sleep in a cool environment, shivering, carbon dioxide production, and body temperature decreased, and ear capillary blood flow and ear skin temperature increased. Shivering associated with rapid cooling was attenuated after dialysis of DPAT into the PGCL. In animals maintained in a continuously cool environment, dialysis of DPAT into the PGCL attenuated shivering and decreased body temperature, but there were no significant increases in ear capillary blood flow or ear skin temperature. We conclude that both naturally occurring REM sleep and exogenous activation of 5-HT(1A) receptors in the PGCL are associated with a suspension of shivering during cooling. Our data are consistent with the hypothesis that 5-HT neurons in the PGCL facilitate oscillating spinal motor circuits involved in shivering but are less involved in modulating sympathetically mediated thermoregulatory mechanisms.


Sujet(s)
Basse température , Moelle allongée/effets des médicaments et des substances chimiques , Noyaux du raphé/effets des médicaments et des substances chimiques , Récepteur de la sérotonine de type 5-HT1A/effets des médicaments et des substances chimiques , Agonistes des récepteurs de la sérotonine/pharmacologie , Frissonnement/effets des médicaments et des substances chimiques , 7-Dipropylamino-5,6,7,8-tétrahydro-1-naphtol/pharmacologie , Animaux , Pression sanguine/effets des médicaments et des substances chimiques , Régulation de la température corporelle/effets des médicaments et des substances chimiques , Dioxyde de carbone/métabolisme , Électroencéphalographie , Électromyographie , Électro-oculographie , Femelle , Rythme cardiaque/effets des médicaments et des substances chimiques , Mâle , Moelle allongée/métabolisme , Microdialyse , Polysomnographie , Noyaux du raphé/métabolisme , Récepteur de la sérotonine de type 5-HT1A/métabolisme , Sommeil paradoxal/effets des médicaments et des substances chimiques , Sommeil paradoxal/physiologie , Suidae , Vasoconstriction/effets des médicaments et des substances chimiques , Vigilance/physiologie
16.
Clin Pharmacol Ther ; 81(3): 425-8, 2007 Mar.
Article de Anglais | MEDLINE | ID: mdl-17339872

RÉSUMÉ

The field of pharmacogenetics has existed since the 1950s, when it was demonstrated that some drug effects could differ substantially among race and ethnic groups, and that some drug metabolizing enzyme activities were inherited. During the 1990s, application of molecular biology to the study of inherited drug-related phenotypes proved the genetic basis of several genetic polymorphisms. Genomic technology has now demonstrated that germline genetic variability among humans is extremely common. The combined weight of proven examples whereby pharmacogenetics affects drugs, and the possibility of even more examples being elucidated in the coming decades, dictates that pharmacogenetics be incorporated into the drug approval process. It is our contention that minimal pharmacogenetic testing should be required for all new drug applications to the Food and Drug Administration (FDA). This would include a requirement for germline DNA to be prospectively collected from all subjects participating in preapproval clinical trials. For drugs that are metabolized by enzymes whose genes have clearly inactivating polymorphisms, clinical trial participants should be genotyped for those polymorphisms.


Sujet(s)
Agrément de médicaments/législation et jurisprudence , Pharmacogénétique/législation et jurisprudence , Pharmacogénétique/tendances , ADN/génétique , Génotype , Humains , Phénotype , Manipulation d'échantillons , États-Unis , Food and Drug Administration (USA)
17.
Phys Med Biol ; 51(20): 5347-62, 2006 Oct 21.
Article de Anglais | MEDLINE | ID: mdl-17019043

RÉSUMÉ

Quantification of myocardial blood flows at rest and stress using 13N-ammonia PET is an established method; however, current techniques require a waiting period of about 1 h between scans. The objective of this study was to test a rapid dual-injection single-scan approach, where 13N-ammonia injections are administered 10 min apart during rest and adenosine stress. Dynamic PET data were acquired in six human subjects using imaging protocols that provided separate single-injection scans as gold standards. Rest and stress data were combined to emulate rapid dual-injection data so that the underlying activity from each injection was known exactly. Regional blood flow estimates were computed from the dual-injection data using two methods: background subtraction and combined modelling. The rapid dual-injection approach provided blood flow estimates very similar to the conventional single-injection standards. Rest blood flow estimates were affected very little by the dual-injection approach, and stress estimates correlated strongly with separate single-injection values (r=0.998, mean absolute difference=0.06 ml min-1 g-1). An actual rapid dual-injection scan was successfully acquired in one subject and further demonstrates feasibility of the method. This study with a limited dataset demonstrates that blood flow quantification can be obtained in only 20 min by the rapid dual-injection approach with accuracy similar to that of conventional separate rest and stress scans. The rapid dual-injection approach merits further development and additional evaluation for potential clinical use.


Sujet(s)
Ammoniac , Vitesse du flux sanguin/physiologie , Circulation coronarienne/physiologie , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/physiologie , Interprétation d'images assistée par ordinateur/méthodes , Tomographie par émission de positons/méthodes , Ammoniac/administration et posologie , Ammoniac/pharmacocinétique , Isotopes du carbone/administration et posologie , Isotopes du carbone/pharmacocinétique , Épreuve d'effort , Femelle , Humains , Amélioration d'image/méthodes , Injections artérielles , Mâle , Adulte d'âge moyen , Technique de dilution radioisotopique , Radiopharmaceutiques/administration et posologie , Reproductibilité des résultats , Repos , Sensibilité et spécificité
18.
Radiat Prot Dosimetry ; 120(1-4): 466-9, 2006.
Article de Anglais | MEDLINE | ID: mdl-16597694

RÉSUMÉ

The personnel dosimetry operations team at the Los Alamos National Laboratory (LANL) has accepted the laser illuminated track etch scattering (LITES) dosemeter reader into its suite of radiation dose measurement instruments. The LITES instrument transmits coherent light from a He-Ne laser through the pertinent track etch foil and a photodiode measures the amount of light scattered by the etched tracks. A small beam stop blocks the main laser light, while a lens refocuses the scattered light into the photodiode. Three stepper motors in the current LITES system are used to position a carousel that holds 36 track etch dosemeters (TEDs). Preliminary work with the LITES system demonstrated the device had a linear response in counting foils subjected to exposures up to 50 mSv (5.0 rem). The United States Department of Energy requires that the annual general employee dose not exceed 50 mSv (5.0 rem). On a regular basis, LANL uses the Autoscan-60 reader system (Thermo Electron Corp.) for counting track etch dosemeters. However, LANL uses a 15 h etch process for CR-39 dosemeters, and this produces more and larger track etch pits than the 6 h etch used by many institutions. Therefore, LANL only uses the Autoscan-60 for measuring neutron dose equivalent up to exposure levels of approximately 3 mSv (300 mrem). The LITES system has a measured lower limit of detection of approximately 0.6 mSv (60 mrem), and it has a correlation coefficient of R (2) = 0.99 over an exposure range up to 500 mSv (50.0 rem). A series of blind studies were done using three methods: the Autoscan-60 system, manual counting by optical microscope and the LITES instrument. A collection of track etch dosemeters of unknown neutron dose equivalent (NDE) were analysed using the three methods, and the performance coefficient (PC) was calculated when the NDE became known. The Autoscan-60 and optical microscope methods had a combined PC = 0.171, and the LITES instrument had a PC = 0.194, where a PC less than or equal to 0.300 is considered satisfactory.


Sujet(s)
Lasers , Radioprotection/instrumentation , Dosimétrie par thermoluminescence/instrumentation , Relation dose-effet des rayonnements , Conception d'appareillage , Analyse de panne d'appareillage , Dose de rayonnement , Reproductibilité des résultats , Sensibilité et spécificité , Propriétés de surface , Dosimétrie par thermoluminescence/méthodes
19.
AMIA Annu Symp Proc ; : 1063, 2006.
Article de Anglais | MEDLINE | ID: mdl-17238682

RÉSUMÉ

We describe the use of verbal protocol analysis for evaluating the textual signals used by pharmacists for detection of adverse drug events (ADEs). "Think aloud" technique was used to gain insight into how pharmacists reason about ADE occurrence, when reading patient progress notes. We used case-scenarios for five ADEs consisting of information regarding patient history, medications, laboratory results, vital signs and patient progress notes. Pharmacists extensively used information present in the progress notes to make inferences about ADEs.


Sujet(s)
Systèmes de signalement des effets indésirables des médicaments , Prise de décision , Effets secondaires indésirables des médicaments , Collecte de données/méthodes , Humains , Pharmaciens
20.
Radiat Prot Dosimetry ; 110(1-4): 549-53, 2004.
Article de Anglais | MEDLINE | ID: mdl-15353707

RÉSUMÉ

Initial calibration of a multisphere spectroscopy system has been completed at Los Alamos National Laboratory using four standard calibration scenarios. Spectrum unfolding was performed using three methods of constructing the default spectrum: simple parameter models, Monte Carlo calculations and physical measurement. Comparisons of the resulting spectra for each solution method are presented. Implications of the spectral solutions upon dosemeter characterisation are addressed.


Sujet(s)
Algorithmes , Analyse de panne d'appareillage/normes , Neutrons , Radioprotection/normes , Radiométrie/normes , Appréciation des risques/normes , Analyse spectrale/normes , Charge corporelle , Conception d'appareillage , Analyse de panne d'appareillage/méthodes , Études de faisabilité , Humains , Transfert linéique d'énergie , Méthode de Monte Carlo , Dose de rayonnement , Radioprotection/instrumentation , Radioprotection/méthodes , Radiométrie/instrumentation , Radiométrie/méthodes , Normes de référence , Efficacité biologique relative , Reproductibilité des résultats , Appréciation des risques/méthodes , Facteurs de risque , Sensibilité et spécificité , Analyse spectrale/instrumentation , Analyse spectrale/méthodes , États-Unis
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE